138 related articles for article (PubMed ID: 22870779)
21. Current advances in sustained-release systems for parenteral drug delivery.
Shi Y; Li LC
Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
[TBL] [Abstract][Full Text] [Related]
22. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
Padamwar MN; Patole MS; Pokharkar VB
J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis.
Réeff J; Oprenyeszk F; Franck T; Goole J; De Vriese C; Serteyn D; Henrotin Y; Amighi K
Int J Pharm; 2015 Jul; 490(1-2):74-84. PubMed ID: 25934426
[TBL] [Abstract][Full Text] [Related]
24. Exploring the use of novel drug delivery systems for antiretroviral drugs.
Ojewole E; Mackraj I; Naidoo P; Govender T
Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
[TBL] [Abstract][Full Text] [Related]
25. Chitosan: a unique polysaccharide for drug delivery.
Felt O; Buri P; Gurny R
Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
[TBL] [Abstract][Full Text] [Related]
26. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs.
Huang WC; Hu SH; Liu KH; Chen SY; Liu DM
J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
28. 'Retarded pharmaceuticals' assuming a clinical role.
Muggia FM
Onkologie; 2004 Oct; 27(5):437-8. PubMed ID: 15585972
[No Abstract] [Full Text] [Related]
29. [Intra-articular injection therapy].
Vojtassák J
Acta Chir Orthop Traumatol Cech; 1991 Mar; 58(1-2):89-97. PubMed ID: 1872115
[TBL] [Abstract][Full Text] [Related]
30. [The possibilities of an individual approach to intra-articular drug administration in rheumatoid arthritis patients].
Matveĭkov GP; Soroka NF; Maksimovich AB
Ter Arkh; 1989; 61(12):121-4. PubMed ID: 2629140
[TBL] [Abstract][Full Text] [Related]
31. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
[No Abstract] [Full Text] [Related]
32. Liposomal nanomedicines.
Fenske DB; Cullis PR
Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
[TBL] [Abstract][Full Text] [Related]
33. Casein-based formulations as promising controlled release drug delivery systems.
Elzoghby AO; El-Fotoh WS; Elgindy NA
J Control Release; 2011 Aug; 153(3):206-16. PubMed ID: 21338636
[TBL] [Abstract][Full Text] [Related]
34. [Intra-articular drug therapy of juvenile rheumatoid arthritis (a review of the literature)].
Revutskaia AE; Okhotnikova EN
Vrach Delo; 1984 Oct; (10):63-6. PubMed ID: 6393582
[No Abstract] [Full Text] [Related]
35. Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M; Mehnert W; Korting HC
Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
[TBL] [Abstract][Full Text] [Related]
36. Delivery of cisplatin from Pluronic co-polymer systems: liposome inclusion and alginate coupling.
Fang JY; Hsu SH; Leu YL; Hu JW
J Biomater Sci Polym Ed; 2009; 20(7-8):1031-47. PubMed ID: 19454167
[TBL] [Abstract][Full Text] [Related]
37. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.
Collnot EM; Ali H; Lehr CM
J Control Release; 2012 Jul; 161(2):235-46. PubMed ID: 22306429
[TBL] [Abstract][Full Text] [Related]
38. Polymer blends for controlled release coatings.
Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722
[TBL] [Abstract][Full Text] [Related]
39. Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Ozbakir B; Crielaard BJ; Metselaar JM; Storm G; Lammers T
J Control Release; 2014 Sep; 190():624-36. PubMed ID: 24878183
[TBL] [Abstract][Full Text] [Related]
40. Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis.
Paganelli F; Cardillo JA; Dare AR; Melo LA; Lucena DR; Silva AA; Oliveira AG; Pizzolitto AC; Lavinsky D; Skaf M; Souza-Filho AA; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Herrero-Vanrell R; Belfort R;
Expert Opin Drug Deliv; 2010 Aug; 7(8):955-65. PubMed ID: 20645672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
